You're not alone: Winnipeg has a vibrant Crohn’s and colitis community, made up of people with inflammatory bowel disease, families, volunteers, and more. Throughout the year, we come together at meetings and events like the Gutsy Walk to share experiences, raise funds and heighten awareness.

There are an estimated 7,500 people with Crohn’s disease or ulcerative colitis in Winnipeg and its surrounding communities. We understand the challenges you and your family may be facing – because we face them, too.
2025 Gutsy and Glamourous Gala Manitoba's flower

2025 Gutsy and Glamourous Gala

Join us for our 16th Annual Gutsy & Glamorous Gala on March 6, 2025. This grand event promises to be an unforgettable evening that you won’t want to miss! A spectacular night of music, fine ...

 • 
The Delta Hotel, 350 St Mary Ave.
Winnepeg
 • 
	Man sitting with his legs up on his couch typing on his laptop

Manitoba Peer Connect Event (with Saskatchewan)

Ready to connect with those who understand the challenges of Crohn’s disease, ulcerative colitis, and other forms of inflammatory bowel disease (IBD)?Join our upcoming Peer Connect event where ...

 • 
Virtual
 • 

Facebook

More on Facebook
 
Remember to bookmark this page.

March 2025

SunMonTueWedThuFriSat
2324252627281
2345678
9101112131415
16171819202122
23242526272829
303112345

News

The Canadian Inflammatory Bowel Disease Research Consortium awards first $1M Pioneer Grant from Takeda Canada

The Canadian Inflammatory Bowel Disease Research Consortium awards first $1M Pioneer Grant from Takeda Canada

Crohn’s and Colitis Canada and Pfizer Canada Announce 2022 Women in IBD Award Recipients

Crohn’s and Colitis Canada and Pfizer Canada Announce 2022 Women in IBD Award Recipients

Health Canada has approved SKYRIZI® (risankizumab) an intravenous and subcutaneous medication treatment for adults with moderately to severely active Crohn's Disease

Health Canada has approved SKYRIZI® (risankizumab) an intravenous and subcutaneous medication treatment for adults with moderately to severely active Crohn's Disease

 14 15 16 17 18 19 20 21 22 23